Pathogenic Escherichia coli genomic DNA (E. coli gDNA)

Pathogenic Escherichia coli genomic DNA is the complete set of genetic material that defines the virulence and metabolic capabilities of disease-causing E. coli strains (Nature Reviews Microbiology, 2018). This DNA contains specific virulence factors, often located on mobile genetic elements like plasmids or pathogenicity islands, which distinguish pathogens from commensal flora (Microbiology and Molecular Biology Reviews, 2000). As a therapeutic target, the genomic DNA is susceptible to damage from drugs like nitroimidazoles, which generate reactive intermediates that cause lethal strand breaks (StatPearls, 2023). It also serves as the basis for rapid molecular diagnostics, allowing for the identification of specific pathotypes such as Shiga toxin-producing E. coli (STEC) through PCR-based detection of marker genes (CDC, 2023). Understanding the genomic landscape of these pathogens is crucial for developing targeted therapies and managing outbreaks of foodborne illness and systemic infections. However, targeting bacterial DNA carries risks, including the potential for off-target effects on the host's mitochondrial DNA and the disruption of the protective gut microbiome (Frontiers in Microbiology, 2020). Furthermore, the rapid evolution of the E. coli genome through horizontal gene transfer facilitates the spread of antibiotic resistance genes, complicating treatment strategies (Journal of Bacteriology, 2019).

Other names

Escherichia coli genomeE. coli chromosomeBacterial genomic DNA

Direct DNA damage through strand breakage, cross-linking, or intercalation, leading to inhibition of replication and transcription.